Ligand Pharmaceuticals (LGND) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Carbon Footprint Conservation Environment Environmental Environmental Protection Escape Forest Green Intensity Materials Natural Resources Nature Offset Oil Package Packaging Pandemic Pollution Recycling Renewable Solar Toxic Waste Water Access Asian Benefits Black California Consumer Privacy Act Charitable Community Culture Customer Cyber Cyber Security Cybersecurity Data Privacy Death Demographic Disability Diversity Diversity and Inclusion Employee Employee Engagement Employee Training Engagement Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Rights Incident Injuries Injury Minority Pay Equity Pay for Performance Perquisites Privacy Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Talent Union Volunteer Women Workers Workforce Workplace Safety Antitrust Assessment Assurance Audit Bonus Chronic Classified Commitment Conflict of Interest Controversy Corporate Governance Corporate Purpose Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Key Performance Indicator Lawsuit Leadership Litigation Long-term Majority Materiality Mission Negative Discretion Oversee Oversight Perquisite Plaintiff Procurement Purpose Quality Standard R&D Reputation Research and Development Responsibility Responsible Strategy Sustainability Sustainable Targets Tax Tax Gross Up Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

Set forth below are the final voting results for the actions taken by the stockholders at the Annual Meeting.

Proposal 1. The election of ten members of the Board for terms expiring at the 2023 annual meeting of stockholders. In accordance with the results below, each nominee was elected to serve as a director.

	Votes For	Votes Withheld	Broker Non-Votes

Jason M. Aryeh	13,315,749	621,116	1,478,696
Sarah Boyce	13,572,966	363,899	1,478,696
Jennifer Cochran, Ph.D.	13,858,540	78,325	1,478,696
Todd C. Davis	13,401,215	535,650	1,478,696
Nancy R. Gray, Ph.D.	13,836,206	100,659	1,478,696
John L. Higgins	13,716,803	220,062	1,478,696
John W. Kozarich, Ph.D.	12,997,421	939,444	1,478,696
John L. LaMattina, Ph.D.	13,479,735	457,130	1,478,696
Sunil Patel	13,751,340	185,525	1,478,696
Stephen L. Sabba, M.D.	13,420,123	516,742	1,478,696

Proposal 2. The ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. In accordance with the results below, the selection of Ernst & Young LLP was ratified.

Votes For	Votes Against	Abstentions	Broker Non-Votes



15,312,173	97,551	5,837	-

Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers. In accordance with the results below, the resolution was approved.

Votes For	Votes Against	Abstentions	Broker Non-Votes



12,892,453	996,180	48,232	1,478,696

Proposal 4. The approval of the Restated Plan. In accordance with the results below, the resolution was approved.

Votes For	Votes Against	Abstentions	Broker Non-Votes


13,136,648	780,269	19,948	1,478,696